• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Transgene - Product Image

Transgene

  • Published: March 2014
  • Region: Global
  • 50 pages
  • Wright Investors Service

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio tables (Accounting, Asset Utilization, Employee Efficiency, Fixed Charges Coverage, Leverage Analysis, Liquidity Analysis, Per-share Data and Profitability Analysis) and proprietary Wright Quality Rating analyses tables. The Wright Quality Rating, a measure of corporate risk, examines the liquidity of the stock, financial strength, profitability and corporate growth characteristics of Transgene. There is a textual review of the financial results of Transgene versus Linkmed AB, Omega Diagnostics Group Plc and Navamedic ASA. The comparative analysis of these companies compares Sales (sales, sales growth and sales per employee), Company Valuations (Price/Earnings, Price/Book, Price/Sales and 52-Week Price Change) and Financial Position (Long-term Debt/Equity). Also included for Transgene are the Company Description, Recent Stock Performance, Profitability Analysis, Dividend Analysis, and Key Data Items (Ticker, Major Industry, Sub-Industry, Fiscal Year End Month, Employees, Share Type, Market Capitalization, Total Shares Outstanding and Number of Closely Held Shares.) Additional research for Transgeneincludes tables with up to 10-years of history of computed ratios, sales, earnings, and security prices.

This product typically includes the following sections:

Company Fundamentals
- Company Profile
- Comparative Business Analysis
- Summary Analysis per Share
- Sales Analysis
- Price Analysis
- Earnings and Dividends Analysis

Financial Statement Analyses
- Balance Sheet - Common Size
- Balance Sheet - Year-Year Percent Change
- Balance Sheet - Five-Year Averages-
- Income Statement - Common Size
- Income Statement - Year-Year Percent Change
- Income Statement - Five-Year Averages-
- Sources of Capital

Financial Ratio Analyses
- Accounting Ratios---
- Asset Utilization---
- Employee Efficiency--
- Fixed Charges Coverage
- Leverage Analysis
- Liquidity Analysis---
- Per-Share Data
- Profitability Analysis

Wright Quality Rating Analyses
- Investment Acceptance
- Financial Strength
- Profitability and Stability
- Corporate Growth

Notes:
- Report is included when there are five or more years of data history.
-- Report is included when employee counts are available.
---These reports are not produced for Financial Companies.

Linkmed AB, Omega Diagnostics Group Plc and Navamedic ASA

Note: Product cover images may vary from those shown

RELATED PRODUCTS

  • Transgene SA - Product Pipeline Review - 2012 - Product Thumbnail Image Transgene SA - Product Pipeline Review - 2012

    Transgene SA - Product Pipeline Review - 2012

    • Published: June 2012
    • Region: Global
    FROM
  • Devgen NV - Product Thumbnail Image

    Devgen NV

    • Published: March 2014
    • Region: Global
  • Innate Pharma S.A. - Product Thumbnail Image

    Innate Pharma S.A.

    • Published: March 2014
    • Region: Global
  • Nicox SA - Product Thumbnail Image

    Nicox SA

    • Published: March 2014
    • Region: Global
  • Probi AB - Product Thumbnail Image

    Probi AB

    • Published: March 2014
    • Region: Global
  • Saamya Biotech (India) Limited - Product Thumbnail Image

    Saamya Biotech (India) Limited

    • Language: English
    • 38 Pages
    • Published: April 2014
    • Region: Global, India
    FROM
  • Transgene Biotek Limited - Product Thumbnail Image

    Transgene Biotek Limited

    • Language: English
    • 40 Pages
    • Published: March 2014
    • Region: Global
    FROM
  • Omega Diagnostics Group Plc - Product Thumbnail Image

    Omega Diagnostics Group Plc

    • Language: English
    • 41 Pages
    • Published: March 2014
    • Region: Global
  • Navamedic ASA - Product Thumbnail Image

    Navamedic ASA

    • Language: English
    • 41 Pages
    • Published: March 2014
    • Region: Global
  • Navamedic ASA (NAVA) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

    Navamedic ASA (NAVA) - Financial and Strategic SWOT Analysis Review

    • Language: English
    • Published: May 2013
    • Region: Global
    FROM